1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDefense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) Broad Agency Announcement (BAA) is sponsored by Defense Advanced Research Projects Agency (DARPA). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DARPA’s Biological Technologies Office Broad Agency Announcement - EverGlade DARPA , Emerging Technologies DARPA’s Biological Technologies Office Broad Agency Announcement Max Higgins, Senior Consultant DARPA BTO Broad Agency Announcement 10. 25 The Defense Advanced Research Projects Agency (DARPA) , through its Biological Technologies Office (BTO), has released a new Broad Agency Announcement (BAA), HR001126S0003, on October 1, 2025.
This solicitation seeks transformative research leveraging biological processes and technologies to enhance warfighter protection and performance. DARPA BTO continues to push the boundaries of biotechnology, not through incremental improvements, but by investing in revolutionary solutions that can redefine the future of defense, medicine, and resilience. DARPA BTO’s mission is to harness biology as a technology for national security.
This BAA invites proposals that use biology to protect warfighters, enhance decision-making, and strengthen resilience against threats. The office is particularly interested in groundbreaking applications of artificial intelligence (AI), machine learning (ML), biotechnology, and bio-inspired engineering that can fundamentally improve military readiness and response capabilities.
The scope of the solicitation spans several research and development areas: AI and ML for Biology: Accelerating biological simulations, developing biological foundation models, and building AI-enabled decision-making tools. Combat Casualty Care: New diagnostics, therapeutics, and decision-support systems for austere and high-threat environments.
Human Performance: Advances in cognition, fatigue mitigation, neural processing, and resilience under extreme stress. Materials and Sensors: Bio-inspired sensors, hybrid systems, and predictive models for new material development. Agriculture & Environment: Solutions to protect food, water, and ecosystems while leveraging non-human biology for operational advantages.
Security, Safety & Surveillance: Biosafety, pathogen detection, and next-generation biodefense solutions. Biomedical Innovation: Rapid manufacturing of therapeutics, novel cellular therapies, and countermeasures against antimicrobial resistance. DARPA BTO has structured this BAA with a rolling submission timeline.
Key deadlines include: Abstracts due: Rolling submissions accepted until September 30, 2026 at 4:00 PM ET. Full proposals due: Rolling submissions accepted until September 30, 2026 at 4:00 PM ET. An abstract must be submitted, and DARPA must provide a notification to submit a full proposal before any full proposal will be reviewed.
DARPA anticipates multiple awards under this BAA. Awards may take the form of Procurement Contracts, Cooperative Agreements, or Other Transaction Agreements (OTs). The agency has also introduced an accelerated award pathway for proposals under $2 million, with awards made within 30 days of selection.
Periods of performance will vary depending on project scope, with flexibility for both short- and long-term efforts. Driving Human Health and Security At its core, this solicitation aims to bolster warfighter resilience while advancing technologies that improve human health.
Whether through innovations in medical countermeasures, enhanced monitoring of physiological readiness, or breakthrough therapeutics, the BTO is funding work that will have direct impact on survival, recovery, and long-term health outcomes for service members and civilians alike.
For organizations considering participation, this BAA represents a unique opportunity to align cutting-edge biotechnology research with DARPA’s national security mission. If your company has considered applying for federal funding, your federal funding journey starts here. EverGlade is a national firm that helps organizations win and manage federal awards.
We offer services ranging from Pursuit, Proposal and Post-Award support to comply with federal regulations at agencies including BARDA , ARPA-H , NIH , DTRA , JPEO , DOD , DIU , DOE , and DARPA . Collaborate with EverGlade We partner with life sciences and technology innovators to secure and execute funding for high-risk, high-impact programs across the federal and commercial sectors.
Prev Previous HHS Operations During A Government Shutdown Sign-up for EverGlade Alerts BARDA’s Draft New Vaccine Platforms RPP Signals a Major Push for Adaptable Medical Countermeasures BARDA Releases RFP for Pandemic Influenza Vaccine Medical Countermeasures NSF’s $1.
5B Foundational Research Funds: Where the Next Wave of Science and Technology Will Start ARPA-H STREAM Program: A New Federal Push for Safer, Smarter Weed Management BARDA’s BioMaP-Consortium Seeks Vendor Managed Inventory Capabilities to Secure the Nation’s API Reserve BARDA’s Next Big Investment Play: Pandemic Preparedness And Domestic Manufacturing 1 thought on “DARPA’s Biological Technologies Office Broad Agency Announcement” For the ag x bio rfp it ways awards are up to 500K.
But it does not say if this is for direct costs only or direct and indirect. Can you clarify Leave a Comment Cancel Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment.
According to the current listing, eligibility includes: Proposers may include universities, non-profit organizations, small businesses, and large businesses. Confirm the full requirements in the official notice before applying.
Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) Broad Agency Announcement (BAA) is funded by Defense Advanced Research Projects Agency (DARPA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
DPA26BZ06-DV023 is a Direct-to-Phase-II SBIR paying $700,000 over 18 months plus a $500,000 option. The physics demands 256x more transmit power than the systems that qualify you to compete, and DARPA will not accept modeling alone as proof. Here is the eligibility wall, the five engineering problems, and who can realistically win it before the October 21 close.
Read articleRelease 6's SBIR topics got the attention. Its three STTR topics — SHIELDER, fuel-flexible electric propulsion, and hypersonic wind tunnel noise diagnostics — are all Direct-to-Phase-II, all require a research institution to perform at least 30 percent of the work, and all close October 21, 2026. The feasibility gates are the real filter.
Read articleDPA26BZ06-DV026 offers $300,000 at Phase I or $1,800,000 as a single Direct-to-Phase-II tranche with no options. The deliverable is a simulated auction market that measures whether AI agents deceive, collude, or manipulate the humans they serve — measured entirely from the outside. Here is the 90% efficiency gate, the team composition most bidders will get wrong, and why this topic sits in DARPA's biology office.
Read article